A quantitative approach to measure and predict microbiome response to antibiotics

Area of Science:

• Microbiome research
• Antibiotic resistance
• Computational biology

Background:

• Antibiotics significantly alter the human microbiome, potentially leading to dysbiosis and resistance.
• Current methods quantify microbiome changes but don't predict antibiotic-specific impacts.
• A systematic, quantitative approach is needed to measure and predict microbiome responses to antibiotics.

Purpose of the Study:

• To introduce a novel method for quantifying and predicting antibiotic-specific microbiome alterations.
• To develop a microbiome response index (MiRIx) for assessing microbiota susceptibility to antibiotics.
• To provide a tool for deeper understanding of the microbiome-antibiotic relationship.

Main Methods:

• Developed a microbiome response index (MiRIx) based on bacterial phenotypes and antibiotic susceptibility data.
• Applied MiRIx to analyze five published microbiome studies involving vancomycin, metronidazole, ciprofloxacin, amoxicillin, and doxycycline.
• Implemented the approach as open-source software compatible with 16S rRNA and shotgun metagenomics data.

Main Results:

• Quantified antibiotic-specific microbiome responses using MiRIx.
• Demonstrated MiRIx's utility in conjunction with existing microbiome analysis techniques.
• Generated predictions of antibiotic responses for oral, skin, and gut microbiomes in healthy individuals.

Conclusions:

• MiRIx offers a systematic and quantitative method to measure and predict microbiome responses to antibiotics.
• The developed software tool enhances the analysis of microbiome data in response to antibiotic interventions.
• This approach has the potential to significantly advance our understanding of microbiome dynamics and antibiotic effects.